Trump Has Been Investing in Companies and Then Pumping Them in His Speeches
President Trump has been actively investing in companies, including Thermo Fisher Scientific, while publicly promoting them. On the same day he toured a Thermo Fisher facility, he purchased between $15,000 and $50,000 worth of the company's stock. Critics argue that this behavior raises ethical concerns regarding conflicts of interest in his role as president.
- ▪Trump purchased between $15,000 and $50,000 of Thermo Fisher stock on the same day he toured its facility.
- ▪He had previously bought between $51,000 and $115,000 worth of Thermo Fisher stock a month before his visit.
- ▪A spokesperson for Trump claimed that his trades are managed by independent financial advisors, but critics question the ethics of his investments.
Mother Jones files mainly under politics. We currently carry 220 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Mother Jones |
| Canonical URL | https://www.motherjones.com/politics/2026/05/donald-trump-trading-buying-stocks-pumping-promoting-companies-speeches-disclosure-corruption-ethical-conflict-interest/ |
| Publication time | Wed, 20 May 2026 11:30:00 +0000 |
| Retrieval time | 2026-05-20T11:34:17.545Z |
| Last seen | 2026-05-20T11:43:31.650Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | dxrrCqQR5kEa |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
.mj-text-cta {display: none;} freestar.config.enabled_slots.push({ placementName: "motherjones_right_rail_1", slotId: "ROS_ATF_300x600" }); President Trump poses with workers during a visit to Thermo Fisher Scientific on March 11, 2026, within a month of purchasing at least $81,000, and as much as $215,000 worth of the company's stock.Julia Demaree Nikhinson/AP Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. This story was originally published by Popular Information, a substack publication to which you can subscribe here. On March 11, President Trump took a tour of a manufacturing facility in Reading, Ohio, owned by Thermo Fisher Scientific, a medical supply company.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Mother Jones.
Discussion
0 commentsMore from Mother Jones
